February, the month of love and friendship, is the perfect excuse to talk about hearts—but not just the ones we draw with arrows on Valentine’s Day cards. I mean the heart that beats in our chest, that impressive life-pumping machine that deserves all our attention and care. And what better way to pamper our cardiovascular engine than by considering supplements that promise to keep it in shape? But are omega-3 and coenzyme Q10 really the allies our heart needs? In this article, we will break down the science behind these popular supplements to determine whether they are true champions in the heart health league or just benchwarmers.
In a world where instant health promises are often sold with the subtlety of a telemarketing commercial, it is crucial to sharpen our skepticism and equip ourselves with verified information. Let’s explore how effective and safe these supplements are according to the latest studies and medical recommendations. Because, at the end of the day, we all want our heart not just to beat, but to do so strongly and without complications.
Omega-3: Heart Heroes or Just Another Myth?
In the battle for a healthy heart, omega-3 fatty acids have been promoted as cardiovascular health superheroes. Fish such as salmon and tuna are famous not only for their taste but also for their abundance of these potentially life-saving substances. But how well-deserved is their reputation?
What Science Says
Science has scrutinized omega-3s, particularly EPA and DHA, to uncover their real impact on cardiovascular health. A notable study in this field is the REDUCE-IT trial, led by researchers from Harvard Medical School and published in the “Journal of the American College of Cardiology.” This study revealed that high doses of EPA could significantly reduce adverse cardiovascular events in individuals with high triglycerides, even while on statin therapy.
However, scientific literature does not present a unanimous consensus. For instance, studies such as OMEGA-REMODEL and VITAL, involving collaborations from institutions like the University of Southampton and the Cleveland Clinic, have shown mixed results. These studies suggest that while some patients may benefit significantly, others may not experience any improvement at all. This underscores a fundamental truth: the benefits of omega-3s vary depending on an individual’s cardiovascular risk profile and other health factors.
Mechanisms of Action of Omega-3: Refining Understanding
Omega-3 fatty acids, especially EPA and DHA, stand out not only for their ability to integrate into cell membranes but also for their key role in cardiovascular health. A study published in the “Journal of Clinical Lipidology” notes that EPA and DHA can reduce triglyceride levels by 15% to 30% in individuals with elevated levels while decreasing C-reactive protein, an inflammatory marker, by up to 40%. These effects, combined with improvements in endothelial function and blood pressure, reinforce their value for cardiovascular disease prevention and management.
On the other hand, their ability to stabilize heart tissue has been widely documented. According to research published in “Progress in Cardiovascular Diseases,” omega-3s reduce the incidence of arrhythmias in high-risk patients. This antiarrhythmic effect complements their ability to improve arterial elasticity and reduce platelet adhesion—factors critical in preventing severe cardiovascular events such as heart attacks and strokes. Additionally, omega-3s interfere with liver triglyceride synthesis, a crucial benefit for patients with hypertriglyceridemia. In this context, studies have shown reductions of up to 30% in triglyceride levels, significantly improving patients’ lipid profiles. This effect is coupled with their ability to lower blood pressure by an average of 4 mmHg systolic and 2 mmHg diastolic when consuming doses of 3 g/day of EPA and DHA.
Beyond traditional benefits, recent research highlights omega-3’s impact on modulating inflammatory processes, acting on molecules like resolvins and lipid mediators that facilitate the resolution of chronic inflammation. These EPA and DHA-derived compounds contribute to immune response regulation and prevent atherosclerotic plaque formation, offering comprehensive protection against cardiovascular diseases. Overall, omega-3 fatty acids not only address classic risk factors such as high triglycerides or inflammation but also act on multiple levels to enhance cardiovascular health holistically. Incorporating them into the diet—whether through natural sources like fatty fish or high-quality supplements—is a strategy backed by robust scientific evidence that benefits both the prevention and treatment of cardiovascular diseases.
Considerations for Consumption: Navigating Benefits and Precautions
The consumption of omega-3 is not a one-size-fits-all solution. The efficacy and safety of these fatty acids depend on multiple factors, including supplementation form, dosage, and source. For example, icosapent ethyl, a purified form of EPA, has shown promising results in studies like REDUCE-IT, where a 25% reduction in major cardiovascular events was observed, highlighting its efficacy in patients with elevated triglycerides. However, other formulations, particularly those combining EPA and DHA, have not shown the same benefits and may be associated with additional risks such as atrial fibrillation, depending on the dose used. According to a recent review, doses exceeding 1 g/day significantly increase the risk of atrial fibrillation compared to lower doses.
Another crucial aspect is supplement quality and purity. High-quality fish oil supplements contain minimal or no contaminants like mercury and dioxins. An analysis published in “Progress in Cardiovascular Diseases” confirmed that omega-3 supplements are “generally recognized as safe” at doses up to 3 g/day, though common side effects include fishy burps and gastrointestinal discomfort. These discomforts can be mitigated by taking the supplements with food or switching to a formulation with a lower oxidation profile.
From an environmental standpoint, sustainable omega-3 consumption is crucial. Sources such as salmon, sardines, and algal oils have gained popularity due to their low environmental impact and high bioavailability. Furthermore, recent advancements in omega-3 food fortification technologies, such as microencapsulation, improve stability and absorption without compromising quality.
Thus, while omega-3s offer clear cardiovascular health benefits, it is essential to choose high-quality sources and consult a healthcare professional before starting any supplementation, especially at high doses. Sustainability and safety should be at the core of any strategy to maximize the benefits of these essential nutrients.
Coenzyme Q10: The Mitochondrial Engine for a Healthy Heart
In the energy machinery of our cells, coenzyme Q10 (CoQ10) is a central figure. This molecule, similar to a spark that ignites mitochondrial engines, is key to energy production in the heart, an organ that demands a constant and abundant ATP supply to beat tirelessly. But how relevant is CoQ10 supplementation for cardiovascular health? Studies provide some encouraging answers.
[…]
As we have explored in this article, omega-3 and coenzyme Q10 are scientifically backed nutritional tools that can significantly benefit heart health when used wisely and appropriately. Whether through their effects on triglyceride regulation, mitochondrial function improvement, or antioxidant capacity, these dietary supplements prove to be valuable allies in cardiovascular care.
At ALANUR, we are committed to providing clear, evidence-based information so that every consumer can make informed health decisions. Dietary supplements are not magical solutions, but when integrated into a balanced diet and healthy lifestyle, they can be an essential pillar in achieving overall well-being.
If you are interested in learning more about the studies and information we have used in this article, we invite you to check our references. Because only through knowledge can we transform daily decisions into smart investments for our health.
Referencias:
- Jafari, M., Mousavi, S. M., Asgharzadeh, A., & Yazdani, N. (2018). Coenzyme Q10 in the treatment of heart failure: A systematic review of systematic reviews. Indian heart journal, 70, S111-S117.
- Pepe, S., Marasco, S. F., Haas, S. J., Sheeran, F. L., Krum, H., & Rosenfeldt, F. L. (2007). Coenzyme Q10 in cardiovascular disease. Mitochondrion, 7, S154-S167.
- Yang, Y. K., Wang, L. P., Chen, L., Yao, X. P., Yang, K. Q., Gao, L. G., & Zhou, X. L. (2015). Coenzyme Q10 treatment of cardiovascular disorders of ageing including heart failure, hypertension and endothelial dysfunction. Clinica Chimica Acta, 450, 83-89.
- Opstad, T. B., Alexander, J., Aaseth, J. O., Larsson, A., Seljeflot, I., & Alehagen, U. (2022). Combined selenium and coenzyme Q10 intervention prevents leukocyte telomere attrition, with association to cardiovascular mortality–A secondary analysis of a randomized clinical trial. Atherosclerosis, 355, 30-31.
- Sue-Ling, C. B., Abel, W. M., & Sue-Ling, K. (2022). Coenzyme Q10 as adjunctive therapy for cardiovascular disease and hypertension: a systematic review. The Journal of Nutrition, 152(7), 1666-1674.
- Dunning, B. J., Bourgonje, A. R., Bulthuis, M. L., Alexander, J., Aaseth, J. O., Larsson, A., … & Alehagen, U. (2023). Selenium and coenzyme Q10 improve the systemic redox status while reducing cardiovascular mortality in elderly population-based individuals. Free Radical Biology and Medicine, 204, 207-214.
- Elagizi, A., Lavie, C. J., Marshall, K., DiNicolantonio, J. J., O’Keefe, J. H., & Milani, R. V. (2018). Omega-3 polyunsaturated fatty acids and cardiovascular health: a comprehensive review. Progress in cardiovascular diseases, 61(1), 76-85.
- Gaengler, S., Sadlon, A., Molino, C. D. G. R. C., Willett, W. C., Manson, J. E., Vellas, B., … & Bischoff-Ferrari, H. A. (2024). Effects of vitamin D, omega-3 and a simple strength exercise programme in cardiovascular disease prevention: The DO-HEALTH randomized controlled trial. The Journal of nutrition, health and aging, 28(2), 100037.
- Wang, Y., Wu, G., Wang, Y., Rehman, A., Yu, L., Zhang, H., … & Wang, X. (2024). Recent developments, challenges, and prospects of dietary omega-3 PUFA-fortified foods: Focusing on their effects on cardiovascular diseases. Food Chemistry, 142498.
- López-Millán, E., Gutiérrez-Uribe, J. A., & Antunes-Ricardo, M. (2024). Omega-3 supplementation: Impact on Low Chronic Inflammation Associated with Obesity. Trends in Food Science & Technology, 104799.
- Ruscica, M., Sirtori, C. R., Carugo, S., Calder, P. C., & Corsini, A. (2022). Omega-3 and cardiovascular prevention–Is this still a choice?. Pharmacological Research, 182, 106342.
- Zhao, H., Guo, M., Yang, C., & Xing, F. (2025). The relationship between serum Omega-6 fatty acids and cardiovascular disease mortality: a competing risks and multivariate Mendelian randomization analysis. Clinical Nutrition ESPEN.
- Elagizi, A., & Lavie, C. J. (2019). Omega-3 Fatty Acids and the Cardiovascular System. In Omega Fatty Acids in Brain and Neurological Health (pp. 213-228). Academic Press.